InvestorsHub Logo
Followers 229
Posts 14579
Boards Moderated 1
Alias Born 03/29/2014

Re: IkeEsq post# 209605

Wednesday, 01/23/2019 2:04:03 PM

Wednesday, January 23, 2019 2:04:03 PM

Post# of 688601
Ike, the question I'd written yesterday in collaboration with Jack, received 6 votes for a yes to ask it.
So please consider those numbers in your choice of questions, as at least some of us think this to be an important question.

Thanks. :)

On at least three occasions, you have released what most would consider good to excellent news - twice presenting clinical information we know as the 2017 and 2018 data, as well as once with good financial news - the recent $49 million sale of Sawston; and yet after each release of this data, we have seen the share price either aggressively attacked immediately back down or even withheld, as was the case with the Sawston sale. I’m sure you’d agree that the share price, when compared to other benchmarks, is not in keeping with where one would reasonably expect it to be.

And from the investigation, which has gone on for 3 to 4 years, you have led some long shareholders to believe that you possess overwhelming evidence of illegal manipulation or naked shorting, and who it is that is behind that illegal manipulation.

Given the fact that the share price is so abysmally low, and that you have claimed to some that you have ample evidence of this, can you put it on record at the ASM and in the minutes that you do indeed have this evidence, that you fully intend to pursue this aggressively on behalf of shareholders; and if so, at what time do you intend to pursue this aggressively - before or after you file a BLA, or before or after you receive an approval for DCVax-L?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News